HomeCompareLIXTW vs KMB

LIXTW vs KMB: Dividend Comparison 2026

LIXTW yields 9049.77% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIXTW wins by $20628078872155540.00M in total portfolio value
10 years
LIXTW
LIXTW
● Live price
9049.77%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20628078872155540.00M
Annual income
$20,189,225,229,131,710,000,000.00
Full LIXTW calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — LIXTW vs KMB

📍 LIXTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIXTWKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIXTW + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIXTW pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIXTW
Annual income on $10K today (after 15% tax)
$769,230.77/yr
After 10yr DRIP, annual income (after tax)
$17,160,841,444,761,954,000,000.00/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, LIXTW beats the other by $17,160,841,444,761,954,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIXTW + KMB for your $10,000?

LIXTW: 50%KMB: 50%
100% KMB50/50100% LIXTW
Portfolio after 10yr
$10314039436077770.00M
Annual income
$10,094,612,614,565,855,000,000.00/yr
Blended yield
97.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

LIXTW
No analyst data
Altman Z
-15.6
Piotroski
2/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIXTW buys
0
KMB buys
0
No recent congressional trades found for LIXTW or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIXTWKMB
Forward yield9049.77%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$20628078872155540.00M$45.9K
Annual income after 10y$20,189,225,229,131,710,000,000.00$5,222.34
Total dividends collected$20598825129197092.00M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LIXTW vs KMB ($10,000, DRIP)

YearLIXTW PortfolioLIXTW Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$915,677$904,977.38$11,314$614.45+$904.4KLIXTW
2$78,425,318$77,445,542.82$12,867$760.19+$78.41MLIXTW
3$6,282,983,839$6,199,068,749.48$14,713$945.27+$6282.97MLIXTW
4$470,866,355,476$464,143,562,767.87$16,924$1,181.90+$470866.34MLIXTW
5$33,012,577,055,280$32,508,750,054,920.79$19,596$1,486.64+$33012577.04MLIXTW
6$2,165,414,967,816,058$2,130,091,510,366,908.20$22,850$1,882.16+$2165414967.79MLIXTW
7$132,896,851,494,306,460$130,579,857,478,743,280.00$26,849$2,399.80+$132896851494.28MLIXTW
8$7,631,926,324,796,117,000$7,489,726,693,697,209,000.00$31,812$3,083.36+$7631926324796.08MLIXTW
9$410,143,591,611,054,950,000$401,977,430,443,523,100,000.00$38,033$3,994.72+$410143591611054.88MLIXTW
10$20,628,078,872,155,540,000,000$20,189,225,229,131,710,000,000.00$45,918$5,222.34+$20628078872155540.00MLIXTW

LIXTW vs KMB: Complete Analysis 2026

LIXTWStock

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Full LIXTW Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this LIXTW vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIXTW vs SCHDLIXTW vs JEPILIXTW vs OLIXTW vs KOLIXTW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.